MARK SOLOMON: Open Payments
NPI 1336151158 · MOUNT SINAI, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 45 payments from 13 companies in 2025. Trend: 2023 $229 · 2024 $652 · 2025 $1,029
Food & beverage: $1,027Education: $2
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $192 |
| Novartis Pharmaceuticals Corporation | 7 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $141 |
| Travere Therapeutics, Inc. | 6 | $104 |
| Amgen Inc. | 4 | $93 |
| Vifor Pharma, Inc. | 3 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
Products named: Ozempic, Fabhalta, Kerendia, JARDIANCE, Veltassa, JYNARQUE, KRYSTEXXA, TAVNEOS.
Industry payments across NY — which companies pay providers there.
